Certain Injectable and Inhalational Sterile Drugs Imported from Ben Venue Laboratories Inc. – Potential Supply Shortage – Notice to Hospitals
Posted: August 17, 2011

Health Canada is advising Healthcare Professionals of a potential supply shortage of certain drugs currently available in Canada. The drugs affected are imported into Canada by a small number of companies from the contract manufacturer Ben Venue Laboratories Inc. (BVL) located in Bedford, Ohio, United States.

BVL is a large contract manufacturer of injectable and inhalational sterile drug products. A recent assessment by Health Canada has identified deficiencies in the area of Good Manufacturing Practices (GMP) at the BVL manufacturing site.


Join us as a member

Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.